Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 43

1.

The emerging role of activins in renal disease.

Mehta N, Krepinsky JC.

Curr Opin Nephrol Hypertens. 2020 Jan;29(1):136-144. doi: 10.1097/MNH.0000000000000560.

PMID:
31714286
2.

The caveolin-1 regulated protein follistatin protects against diabetic kidney disease.

Zhang D, Gava AL, Van Krieken R, Mehta N, Li R, Gao B, Desjardins EM, Steinberg GR, Hawke T, Krepinsky JC.

Kidney Int. 2019 Nov;96(5):1134-1149. doi: 10.1016/j.kint.2019.05.032. Epub 2019 Jun 17.

PMID:
31492508
3.

GDF10 blocks hepatic PPARγ activation to protect against diet-induced liver injury.

Platko K, Lebeau PF, Byun JH, Poon SV, Day EA, MacDonald ME, Holzapfel N, Mejia-Benitez A, Maclean KN, Krepinsky JC, Austin RC.

Mol Metab. 2019 Sep;27:62-74. doi: 10.1016/j.molmet.2019.06.021. Epub 2019 Jun 28.

4.

Follistatin Protects Against Glomerular Mesangial Cell Apoptosis and Oxidative Stress to Ameliorate Chronic Kidney Disease.

Mehta N, Gava AL, Zhang D, Gao B, Krepinsky JC.

Antioxid Redox Signal. 2019 Sep 10;31(8):551-571. doi: 10.1089/ars.2018.7684. Epub 2019 Jul 3.

PMID:
31184201
5.

Caveolin-1 regulation of Sp1 controls production of the antifibrotic protein follistatin in kidney mesangial cells.

Mehta N, Zhang D, Li R, Wang T, Gava A, Parthasarathy P, Gao B, Krepinsky JC.

Cell Commun Signal. 2019 Apr 17;17(1):37. doi: 10.1186/s12964-019-0351-5.

6.

Parathyroid hormone-related protein induces fibronectin up-regulation in rat mesangial cells through reactive oxygen species/Src/EGFR signaling.

Chen HM, Dai JJ, Zhu R, Peng FF, Wu SZ, Yu H, Krepinsky JC, Zhang BF.

Biosci Rep. 2019 Apr 26;39(4). pii: BSR20182293. doi: 10.1042/BSR20182293. Print 2019 Apr 30.

7.

Cell surface expression of 78-kDa glucose-regulated protein (GRP78) mediates diabetic nephropathy.

Van Krieken R, Mehta N, Wang T, Zheng M, Li R, Gao B, Ayaub E, Ask K, Paton JC, Paton AW, Austin RC, Krepinsky JC.

J Biol Chem. 2019 May 10;294(19):7755-7768. doi: 10.1074/jbc.RA118.006939. Epub 2019 Mar 26.

PMID:
30914477
8.

Anti-GRP78 autoantibodies induce endothelial cell activation and accelerate the development of atherosclerotic lesions.

Crane ED, Al-Hashimi AA, Chen J, Lynn EG, Won KD, Lhoták Š, Naeim M, Platko K, Lebeau P, Byun JH, Shayegan B, Krepinsky JC, Rayner KJ, Marchiò S, Pasqualini R, Arap W, Austin RC.

JCI Insight. 2018 Dec 20;3(24). pii: 99363. doi: 10.1172/jci.insight.99363.

9.

Inhibition of SREBP With Fatostatin Does Not Attenuate Early Diabetic Nephropathy in Male Mice.

Van Krieken R, Marway M, Parthasarathy P, Mehta N, Ingram AJ, Gao B, Krepinsky JC.

Endocrinology. 2018 Mar 1;159(3):1479-1495. doi: 10.1210/en.2018-00093.

PMID:
29420703
10.

Regulation of profibrotic responses by ADAM17 activation in high glucose requires its C-terminus and FAK.

Li R, Wang T, Walia K, Gao B, Krepinsky JC.

J Cell Sci. 2018 Feb 20;131(4). pii: jcs208629. doi: 10.1242/jcs.208629.

11.

Dual roles of parathyroid hormone related protein in TGF-β1 signaling and fibronectin up-regulation in mesangial cells.

Wu SZ, Yang SJ, Chen HM, Peng FF, Yu H, Krepinsky JC, Zhang BF.

Biosci Rep. 2017 Oct 27;37(5). pii: BSR20171061. doi: 10.1042/BSR20171061. Print 2017 Oct 31.

12.

Caveolin-1 in the Pathogenesis of Diabetic Nephropathy: Potential Therapeutic Target?

Van Krieken R, Krepinsky JC.

Curr Diab Rep. 2017 Mar;17(3):19. doi: 10.1007/s11892-017-0844-9. Review.

PMID:
28283950
13.

Endoplasmic reticulum stress inhibition attenuates hypertensive chronic kidney disease through reduction in proteinuria.

Mohammed-Ali Z, Lu C, Marway MK, Carlisle RE, Ask K, Lukic D, Krepinsky JC, Dickhout JG.

Sci Rep. 2017 Feb 2;7:41572. doi: 10.1038/srep41572.

14.

Sterol Regulatory Element Binding Protein (SREBP)-1 is a novel regulator of the Transforming Growth Factor (TGF)-β receptor I (TβRI) through exosomal secretion.

Van Krieken R, Chen G, Gao B, Read J, Al Saleh HA, Li R, Al-Nedawi K, Krepinsky JC.

Cell Signal. 2017 Jan;29:158-167. doi: 10.1016/j.cellsig.2016.11.004. Epub 2016 Nov 5.

PMID:
27826032
15.

SREBP inhibition ameliorates renal injury after unilateral ureteral obstruction.

Mustafa M, Wang TN, Chen X, Gao B, Krepinsky JC.

Am J Physiol Renal Physiol. 2016 Sep 1;311(3):F614-25. doi: 10.1152/ajprenal.00140.2016. Epub 2016 Jul 6.

16.

High Glucose Up-regulates ADAM17 through HIF-1α in Mesangial Cells.

Li R, Uttarwar L, Gao B, Charbonneau M, Shi Y, Chan JS, Dubois CM, Krepinsky JC.

J Biol Chem. 2015 Aug 28;290(35):21603-14. doi: 10.1074/jbc.M115.651604. Epub 2015 Jul 14.

17.

SREBP-1 Mediates Angiotensin II-Induced TGF-β1 Upregulation and Glomerular Fibrosis.

Wang TN, Chen X, Li R, Gao B, Mohammed-Ali Z, Lu C, Yum V, Dickhout JG, Krepinsky JC.

J Am Soc Nephrol. 2015 Aug;26(8):1839-54. doi: 10.1681/ASN.2013121332. Epub 2014 Nov 14.

18.

SREBP-1 is a novel mediator of TGFβ1 signaling in mesangial cells.

Chen G, Wang T, Uttarwar L, vanKrieken R, Li R, Chen X, Gao B, Ghayur A, Margetts P, Krepinsky JC.

J Mol Cell Biol. 2014 Dec;6(6):516-30. doi: 10.1093/jmcb/mju041. Epub 2014 Oct 26.

PMID:
25348957
19.

Colchicine attenuates renal injury in a model of hypertensive chronic kidney disease.

Guan T, Gao B, Chen G, Chen X, Janssen M, Uttarwar L, Ingram AJ, Krepinsky JC.

Am J Physiol Renal Physiol. 2013 Nov 15;305(10):F1466-76. doi: 10.1152/ajprenal.00057.2013. Epub 2013 Aug 14.

20.

Caveolin-1 deficiency protects against mesangial matrix expansion in a mouse model of type 1 diabetic nephropathy.

Guan TH, Chen G, Gao B, Janssen MR, Uttarwar L, Ingram AJ, Krepinsky JC.

Diabetologia. 2013 Sep;56(9):2068-77. doi: 10.1007/s00125-013-2968-z. Epub 2013 Jun 21.

PMID:
23793581

Supplemental Content

Loading ...
Support Center